Cargando…
Melanoma Peptide MHC Specific TCR Expressing T-Cell Membrane Camouflaged PLGA Nanoparticles for Treatment of Melanoma Skin Cancer
Melanoma is one of the most aggressive skin cancers, and the American Cancer Society reports that every hour, one person dies from melanoma. While there are a number of treatments currently available for melanoma (e.g., surgery, chemotherapy, immunotherapy, and radiation therapy), they face several...
Autores principales: | Yaman, Serkan, Ramachandramoorthy, Harish, Oter, Gizem, Zhukova, Daria, Nguyen, Tam, Sabnani, Manoj K., Weidanz, Jon A., Nguyen, Kytai T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431670/ https://www.ncbi.nlm.nih.gov/pubmed/32850765 http://dx.doi.org/10.3389/fbioe.2020.00943 |
Ejemplares similares
-
Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy
por: Yaman, Serkan, et al.
Publicado: (2020) -
Development of a Smart Portable Hypoxic Chamber with Accurate Sensing, Control and Visualization of In Vitro Cell Culture for Replication of Cancer Microenvironment
por: Ramachandramoorthy, Harish, et al.
Publicado: (2023) -
Measuring TCR-pMHC Binding In Situ using a FRET-based Microscopy Assay
por: Axmann, Markus, et al.
Publicado: (2015) -
Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions
Publicado: (1996) -
MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers
por: Tran, Nhat, et al.
Publicado: (2018)